The report alleged that Indian-made artillery shells, originally sold to European nations, have been diverted to Ukraine.

The findings, in which doublet immunotherapy added to standard FOLFOX chemotherapy did not improve progression-free survival, ...

Indian munitions are being diverted by European intermediaries to support Ukraine's defence against Russia, according to ...

The primary ... treatment arms, 72.1% to 76.1% of patients completed neoadjuvant therapy, 92.1% to 95.8% underwent surgery, 89.7% to 96.2% had R0 surgical outcomes, and 74.1% to 83.6% started ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Patients with NSCLC did not see a disease-free survival benefit with Imfinzi after surgery compared with taking a placebo.

1. (409) Now, when Titus was come into this [upper ... Caesar gave orders that they should kill none but those that were in arms, and opposed them, but should take the rest alive.

The phase IIIA trials randomized 792 patients ages 12 and older with severe asthma in a 2:1 ratio to depemokimab (100 mg ...

Treatment with Cyramza plus Lonsurf did not improve overall survival compared with Lonsurf alone in heavily pretreated ...

The combination of ramucirumab with trifluridine/tipiracil failed to show improvements in overall survival vs TAS-102 alone ...

The lack of a disease-free survival benefit with adjuvant durvalumab in early-stage resected non-small cell lung cancer in ...